Publications by authors named "Sviatoslav Chekhun"
Article Synopsis
- Third-generation EGFR-TKIs are effective for certain lung cancer patients, helping them live longer despite their cancer.
- Sometimes, after using these treatments for a while, cancer can still grow in certain areas, which is called oligoprogression.
- In one case, a patient had surgery three years after starting treatment, and they are still doing well, showing that special care for these cases can lead to better outcomes.